Comparative evaluation of three recombinant antigen-based enzyme immunoassays for detection of IgM and IgG antibodies to human parvovirus B19

Clinical and Diagnostic Virology

Volumn 9, Issue 1, 1998, Pages 57-63

  Pickering, Jerry W ^a   Forghani, Bagher ^b   Shell, Gordon R ^b   Wu, Linxian ^a  

^a Gull Laboratories Inc   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

EIA; IgG; IgM; Parvovirus B19

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; PARVOVIRUS; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, VIRAL; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRUS B19, HUMAN; REAGENT KITS, DIAGNOSTIC;

EID: 0345196004     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(97)10004-6     Document Type: Article

References (32)

1. Anderson L.J., Hurwitz E.S. Human B19 and Pregnancy. Clin Perinat. 15:1988;273-286.
2. Anderson M.J., Davis L.R., Jones S.E., Pattison J.R., Serjeant G.R. The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg Epidemiol Microbiol Immunol. 88:1982;309-324.
3. Anderson M.J., Higgins P.G., Davis L.R., William J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A.J. Experimental parvoviral infection in humans. J Infect Dis. 152:1985;257-265.
4. Brown C.S., Jensen T., Meloen R.H., Puijk W., Sugamura K., Sato H., Spaan W.J.M. Localization of an immunodominant domain on baculovirus produced parvovirus B19 capsids: Correlation to a major surface region on the native virus particle. J Virol. 66:1992;6989-6996.
5. Brown C.S., Salimans M.M.M., Noteborn M.H.M., Weiland H.T. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res. 15:1990;197-212.
6. Brown C.S., van Bussel M.J.A.W.M., Wassenaar A.L.M., van Elsacker-Niele A.M.W., Weiland H.T., Salimans M.M. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods. 29:1990;53-62.
7. Brown K.K., Young N.S. Parvovirus B19 in human disease. Annu Rev Med. 48:1997;59-67.
8. Bruu A.L., Nordbo S.A. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol. 33:1995;1363-1365.
9. Cohen B.J., Bates C.M. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Methods. 55:1995;11-25.
10. Cohen B.J., Buckley M.M. The prevalence of human parvovirus B19 in England and Wales. Med Microbiol Immunol. 25:1988;151-153.
11. Cohen B.J., Mortimer P.P., Pereira M.S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg Camb. 91:1983;113-130.
12. Fridell E., Trojnar J., Warren B. A new peptide for human parvovirus antibody detection. Scand J Infect Dis. 21:1989;597-603.
13. Gray J.J., Cohen B.J., Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Methods. 44:1993;11-24.
14. Gray J.J., Roth C., Swygart C., Desselberger U. Human parvovirus B19 serology with recombinant VP1 and VP2 antigens: diagnosis of acute infections by detecting B19-specific IgM and IgA antibodies. Clin Diagn Virol. 2:1994;331-341.
15. Jensen I.P., Vestergaard B.F. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Clin Diagn Virol. 7:1997;133-137.
16. Kajigaya S., Shimada T., Fujita S., Young N.S. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci USA. 86:1989;7601-7605.
17. Koch W.C. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. J Virol Methods. 55:1995;67-82.
18. Koch W.C., Massey G., Russel C.E., Adler S.P. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr. 116:1990;355-359.
19. Kurtz J.B., Anderson M.J. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet. 2:1985;1356.
20. Loughrey A.C., O'Neill H.J., Coyle P.V., DeLeys R. Identification and use of a neutralising epitope of parvovirus B19 for the rapid detection of virus infection. J Med Virol. 39:1993;97-100.
21. O'Neill H.J., Venugopal K., Coyle P.V., Gould E. Development of an IgM capture assay for the diagnosis of B19 parvovirus infection using recombinant baculoviruses expressing VP1 and VP2 antigens. Clin Diagn Virol. 3:1995;181-190.
22. Patou G., Ayliffe U. Evaluation of a commercial enzyme linked immunosorbant assay for detection of B19 parvovirus IgM and IgG. J Clin Pathol. 44:1991;831-834.
23. Rayment F.B., Crosdale E., Morris D.J., Pattison J.R., Talbot P., Clare J.J. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. J Gen Virol. 71:1990;2665-2672.
24. Salimans M.M.M., van Bussel M.J.A.W.M., Brown C.S., Spaan W.J.M. Recombinant parvovirus B19 capsids as new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. J Virol Methods. 39:1992;247-258.
25. Sato H., Hirata J., Furukawa M., Kuroda N., Shiraki H., Maeda Y., Okochi K. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. J Virol. 65:1991;1667-1672.
26. Schwarz T.F., Modrow S., Hottentrager B., Hoflacher B., Jager G., Schartl W., Sumazaki R., Wolf H., Middeldorp J., Roggendorf M., Deinhardt F. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies. J Clin Microbiol. 29:1991;431-435.
27. Sisk W.P., Berman M.L. Expression of human parvovirus B19 structural protein in E. coli and detection of antiviral antibodies in human serum. Biotechnology. 5:1987;1077-1080.
28. Soderlund M., Brown C.S., Cohen B.J., Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis. 171:1995;710-713.
29. Soderlund M., Brown K.E., Meurman O., Hedman K. Procaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol. 30:1992;305-311.
30. Wong S., Momoeda M., Fiels A., Kajigaka S., Young N.S. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. J Virol. 68:1994;4690-4694.
31. Yoshimoto K., Rosenfeld S., Frickhofen N., Kennedy D., Hills R., Kajigaya S., Young N.S. A second netralizing epitope of B19 parvovirus implicates the spike region in the immune response. J Virol. 65:1991;7056-7060.
32. Young N.S. B19 parvovirus. Baillieres Clin Haematol. 8(25)(56):1995;1995.